Lewis H. Titterton Jr., Director at Anixa Biosciences Inc (ANIX), bought 7,432 shares at $2.60 ($20K) on 2024-06-10, disclosed to the SEC on 2024-06-12.
Open-market purchase of $20k ANIX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.60 | 330 | $858 | 4.3% |
| 2 | $2.66 | 7,102 | $19K | 95.7% |
| Total | $2.66 avg | 7,432 | $20K | 100% |
| Filing → |
| ANIX | BUY | 2026-07-20 | $42K | — | Filing → |
| ANIX | BUY | 2026-07-16 | $9K | — | Filing → |
| ANIX | BUY | 2026-06-17 | $7K | — | Filing → |